Differential effects of histone deacetylase inhibitors on phorbol ester- and TGF-β1 induced murine tissue inhibitor of metalloproteinases-1 gene expression

FEBS Journal

Volumn 272, Issue 8, 2005, Pages 1912-1926

  Young, David A ^a,b   Billingham, Olivia ^a   Sampieri, Clara L ^a   Edwards, Dylan R ^a   Clark, Ian M ^a  

^a UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Acetylation; c Jun; TGF ; TIMP; Trichostatin A

Indexed keywords

BUTYRIC ACID; HISTONE; HISTONE DEACETYLASE INHIBITOR; PHORBOL ESTER; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA1; TRICHOSTATIN A;

ACETYLATION; ANIMAL CELL; ARTICLE; AVIAN ERYTHROBLASTOSIS ONCOVIRUS; CONTROLLED STUDY; ENZYME INHIBITION; GENE DELETION; GENE EXPRESSION REGULATION; GENE INDUCTION; GENE MUTATION; GENE REPRESSION; MOUSE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN MOTIF; PROTEIN SYNTHESIS; V ETS GENE;

ANIMALS; BASE SEQUENCE; CELL LINE; ENZYME INHIBITORS; GENE EXPRESSION REGULATION; GENES, FOS; GENES, JUN; HISTONE DEACETYLASES; HYDROXAMIC ACIDS; MICE; MOLECULAR SEQUENCE DATA; MUTATION; PROMOTER REGIONS (GENETICS); PROTEIN BIOSYNTHESIS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-ETS; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-JUN; RESPONSE ELEMENTS; TETRADECANOYLPHORBOL ACETATE; TIME FACTORS; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 17444362593     PISSN: 1742464X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2005.04622.x     Document Type: Article

References (49)

1. Egeblad M & Werb Z (2002) New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2, 161-174.
2. Brinckerhoff CE & Matrisian LM (2002) Matrix metalloproteinases: a tail of a frog that became a prince. Nat Rev Mol Cell Biol 3, 207-214.
3. Baker AH, Edwards DR & Murphy G (2002) Metalloproteinase inhibitors: biological actions and therapeutic opportunities. J Cell Sci 115, 3719-3727.
4. Edwards DR, Leco KJ, Leco PA, Lim MS, Phillips BW, Raja J & Sharma R (2000) Regulation of TIMP gene expression. In Tissue inhibitors of metalloproteinases in development and disease (Hawkes SP, Edwards DR & Khokha R, eds), pp. 13-24. Harwood Academic Press, Lausanne, Switzerland.
5. Brand K (2002) Cancer gene therapy with tissue inhibitors of metalloproteinases (TIMPs). Curr Gene Ther 2, 255-271.
6. Edwards DR, Rocheleau H, Sharma RR, Wills AJ, Cowie A, Hassell JA & Heath JK (1992) Involvement of AP1 and PEA3 binding sites in the regulation of murine tissue inhibitor of metalloproteinases-1 (TIMP-1) transcription. Biochim Biophys Acta 1171, 41-55.
7. Clark IM, Rowan AD, Edwards DR, Bech-Hansen T, Mann DA, Bahr MJ & Cawston TE (1997) Transcriptional activity of the human tissue inhibitor of metalloproteinases 1 (TIMP-1) gene in fibroblasts involves elements in the promoter. Exon 1 Intron 1, Biochem J 324, 611-617.
8. Phillips BW, Sharma R, Leco PA & Edwards DR (1999) A sequence-selective single-strand DNA-binding protein regulates basal transcription of the murine tissue inhibitor of metalloproteinases-1 (Timp-1) gene. J Biol Chem 274, 22197-22207.
9. Norman JT, Clark IM & Garcia PL (2000) Hypoxia promotes fibrogenesis in human renal fibroblasts. Kidney Int 58, 2351-2366.
10. Dean G, Young DA, Edwards DR & Clark IM (2000) The human tissue inhibitor of metalloproteinases (TIMP)-1 gene contains repressive elements within the promoter and intron 1. J Biol Chem 275, 32664-32671.
11. Hall MC, Young DA, Waters JG, Rowan AD, Chantry A, Edwards DR & Clark IM (2003) The comparative role of activator protein 1 and Smad factors in the regulation of Timp-1 and MMP-1 gene expression by transforming growth factor-beta 1. J Biol Chem 278, 10304-10313.
12. Wolffe AP & Guschin D (2000) Review: chromatin structural features and targets that regulate transcription. J Struct Biol 129, 102-122.
13. Narlikar GJ, Fan HY & Kingston RE (2002) Cooperation between complexes that regulate chromatin structure and transcription. Cell 108, 475-487.
14. Sudarsanam P & Winston F (2000) The Swi/Snf family nucleosome-remodeling complexes and transcriptional control. Trends Genet 16, 345-351.
15. Kouzarides T (2000) Acetylation: a regulatory modification to rival phosphorylation? Embo J 19, 1176-1179.
16. Clayton AL, Rose S, Barratt MJ & Mahadevan LC (2000) Phosphoacetylation of histone H3 on c-fos- and c-Jun-associated nucleosomes upon gene activation. Embo J 19, 3714-3726.
17. Ng HH & Bird A (2000) Histone deacetylases: silencers for hire. Trends Biochem Sci 25, 121-126.
18. Berger SL (2002) Histone modifications in transcriptional regulation. Curr Opin Genet Dev 12, 142-148.
19. Gao L, Cueto MA, Asselbergs F & Atadja P (2002) Cloning and functional characterization of HDAC11, a novel member of the human histone deacetylase family. J Biol Chem 277, 25748-25755.
20. Braun H, Koop R, Ertmer A, Nacht S & Suske G (2001) Transcription factor Sp3 is regulated by acetylation. Nucleic Acids Res 29, 4994-5000.
21. Vries RG, Prudenziati M, Zwartjes C, Verlaan M, Kalkhoven E & Zantema A (2001) A specific lysine in c-Jun is required for transcriptional repression by E1A and is acetylated by p300. EMBO J 20, 6095-6103.
22. Yoshida M, Kijima M, Akita M & Beppu T (1990) Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. J Biol Chem 265, 17174-17179.
23. Kruh J (1982) Effects of sodium butyrate, a new pharmacological agent, on cells in culture. Mol Cell Biochem 42, 65-82.
24. Gottlicher M, Minucci S, Zhu P, Kramer OH, Schimpf A, Giavara S, Sleeman JP, Lo Coco F, Nervi C, Pelicci PG & Heinzel T (2001) Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. EMBO J 20, 6969-6978.
25. Leco KJ, Khokha R, Pavloff N, Hawkes SP & Edwards DR (1994) Tissue inhibitor of metalloproteinases-3 (TIMP-3) is an extracellular matrix-associated protein with a distinctive pattern of expression in mouse cells and tissues. J Biol Chem 269, 9352-9360.
26. Qin H, Sun Y & Benveniste EN (1999) The transcription factors Sp1, Sp3, and AP-2 are required for constitutive matrix metalloproteinase-2 gene expression in astroglioma cells. J Biol Chem 274, 29130-29137.
27. Bernstein BE, Tong JK & Schreiber SL (2000) Genome-wide studies of histone deacetylase function in yeast. Proc Natl Acad Sci USA 97, 13708-13713.
28. Saunders N, Dicker A, Popa C, Jones S & Dahler A (1999) Histone deacetylase inhibitors as potential anti-skin cancer agents. Cancer Res 59, 399-404.
29. Pujuguet P, Radisky D, Levy D, Lacza C & Bissell MJ (2001) Trichostatin A inhibits beta-casein expression in mammary epithelial cells. J Cell Biochem 83, 660-670.
30. Nair AR, Boersma LJ, Schiltz L, Chaudhry MA, Muschel RJ & Chaudry A (2001) Paradoxical effects of trichostatin A: inhibition of NF-Y-associated histone acetyltransferase activity, phosphorylation of hGCN5 and downregulation of cyclin A B1 Mrna. Cancer Lett 166, 55-64.
31. Mulholland NM, Soeth E & Smith CL (2003) Inhibition of MMTV transcription by HDAC inhibitors occurs independent of changes in chromatin remodeling and increased histone acetylation. Oncogene 22, 4807-4818.
32. Thomson S, Clayton AL & Mahadevan LC (2001) Independent dynamic regulation of histone phosphorylation and acetylation during immediate-early gene induction. Mol Cell 8, 1231-1241.
33. Morton S, Davis RJ, McLaren A & Cohen P (2003) A reinvestigation of the multisite phosphorylation of the transcription factor c-Jun. EMBO J 22, 3876-3886.
34. Weiss C, Schneider S, Wagner EF, Zhang X, Seto E & Bohmann D (2003) JNK phosphorylation relieves HDAC3-dependent suppression of the transcriptional activity of c-Jun. EMBO J 22, 3686-3695.
35. Papavassiliou AG, Chavrier C & Bohmann D (1992) Phosphorylation state and DNA-binding activity of c-Jun depend on the intracellular concentration of binding sites. Proc Natl Acad Sci USA 89, 11562-11565.
36. Fischle W, Dequiedt F, Hendzel MJ, Guenther MG, Lazar MA, Voelter W & Verdin E (2002) Enzymatic activity associated with class II HDACs is dependent on a multiprotein complex containing HDAC3 and SMRT/N-CoR. Mol Cell 9, 45-57.
37. Musti AM, Treier M & Bohmann D (1997) Reduced ubiquitin-dependent degradation of c-Jun after phosphorylation by MAP kinases. Science 275, 400-402.
38. Wertz IE, O'Rourke KM, Zhang Z, Dornan D, Arnott D, Deshaies RJ & Dixit VM (2004) Human de-etiolated-1 regulates c-Jun by assembling a CUL4A ubiquitin ligase. Science 303, 1371-1374.
39. de Ruijter AJ, van Gennip AH, Caron HN, Kemp S & van Kuilenburg AB (2003) Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem J 370, 737-749.
40. Reeves R, Gorman CM & Howard B (1985) Minichromosome assembly of non-integrated plasmid DNA transfected into mammalian cells. Nucleic Acids Res 13, 3599-3615.
41. Jeong S & Stein A (1994) Micrococcal nuclease digestion of nuclei reveals extended nucleosome ladders having anomalous DNA lengths for chromatin assembled on non-replicating plasmids in transfected cells. Nucleic Acids Res 22, 370-375.
42. Lee M, Song SU, Ryu JK & Suh JK (2004) Sp1-dependent regulation of the tissue inhibitor of metalloproteinases-1 promoter. J Cell Biochem 91, 1260-1268.
43. Majello B, De Luca P & Lania L (1997) Sp3 is a bifunctional transcription regulator with modular independent activation and repression domains. J Biol Chem 272, 4021-4026.
44. Ammanamanchi S, Freeman JW & Brattain MG (2003) Acetylated sp3 is a transcriptional activator. J Biol Chem 278, 35775-35780.
45. Logan SK, Garabedian MJ, Campbell CE & Werb Z (1996) Synergistic transcriptional activation of the tissue inhibitor of metalloproteinases-1 promoter via functional interaction of AP-1 and Ets-1 transcription factors. J Biol Chem 271, 774-782.
46. Czuwara-Ladykowska J, Sementchenko VI, Watson DK & Trojanowska M (2002) Ets1 is an effector of the transforming growth factor beta (TGF-beta) signaling pathway and an antagonist of the profibrotic effects of TGF-beta. J Biol Chem 277, 20399-20408.
47. Gregoretti IV, Lee YM & Goodson HV (2004) Molecular evolution of the histone deacetylase family: functional implications of phylogenetic analysis. J Mol Biol 338, 17-31.
48. Gurvich N, Tsygankova OM, Meinkoth JL & Klein PS (2004) Histone deacetylase is a target of valproic acid-mediated cellular differentiation. Cancer Res 64, 1079-1086.
49. Young DA, Phillips BW, Lundy C, Nuttall RK, Hogan A, Schultz GA, Leco KJ, Clark IM & Edwards DR (2002) Identification of an initiator-like element essential for the expression of the tissue inhibitor of metalloproteinases-4 (Timp-4) gene. Biochem J 364, 89-99.